FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.240
+0.035 (2.90%)
At close: Oct 2, 2026, 4:00 PM EDT
1.190
-0.050 (-4.03%)
Pre-market: Oct 5, 2026, 6:06 AM EDT
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,209,267
Market Cap
8.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Enlivex | 34 |
| Moleculin Biotech | 17 |
| Soligenix | 14 |
| Azitra | 13 |
| Ensysce Biosciences | 10 |
| Aprea Therapeutics | 8 |
| CNS Pharmaceuticals | 8 |
FBLG News
- 5 days ago - FibroBiologics announces grant of European patent - TheFly
- 5 days ago - FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity - PRNewsWire
- 12 days ago - FibroBiologics Transcript: Investor update - Transcripts
- 17 days ago - FibroBiologics Transcript: EGM 2026 - Transcripts
- 17 days ago - FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer - PRNewsWire
- 18 days ago - FibroBiologics Slides: Corporate presentation - Filings
- 26 days ago - FibroBiologics Proxy statement: Proxy filing - Filings
- 4 weeks ago - FibroBiologics announces USPTO issued patent on use of fibroblasts - TheFly